database

Staff of the blog Retraction Watch will create a database of papers retracted from the scientific literature.

Nature’s publisher launches a new peer-reviewed, online-only journal that will accept descriptions of data sets.

From research results to electronic health records, biomedical data are becoming increasingly accessible. How can scientists best capitalize on the information deluge?

With scientific budgets eroding, the biomedical community needs to get more return from the data it has already generated.

As scientific publications age, the data that undergird them are disappearing at an alarming rate.

The U.K.’s newly launched Personal Genome Project seeks volunteers.  

Biotech entrepreneur Stephen Friend shares his thoughts on how cancer researchers can collaborate more effectively to achieve faster progress.

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

The largest collection of genetic and medical data in the United States links telomeres and genetic variants to longevity and disease.

Giving researchers access to the health records of 52 million people in England could prove invaluable to biomedical scientists.

Reduced support from the US National Library of Medicine threatens to shut down five popular biological databases.

As we stand on the brink of a new scientific age, how researchers should best communicate their findings and innovations is hotly debated in the publishing trenches.

How to get the most out of your collaboration with bioinformaticians

Growing databanks are invaluable to biomedical researchers, but patients are often unaware of what their information is used for.

Introducing DELSA Global, a community initiative to connect experts, share data, and democratize science.

A new technique to derive DNA information from non-DNA sources, such as RNA, threatens the anonymity of genetic database donors.

The Obama administration pledges $200 million for better ways of managing and extracting information from large data sets.

Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.